Position in NBIX
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$1,070,397
+$431,590 QoQ
Shares Held
6,351
+31.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#391
of 775 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sequoia Financial Advisors, LLC holds $18,226,773 across 16 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
190,940 | $6,469,047 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
162,082 | $2,348,568 | |
| 3 | VTRS |
Viatris Inc
|
93,790 | $1,489,385 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
87,929 | $1,409,501 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
2,530 | $1,370,829 | |
| 6 | ZTS |
Zoetis Inc.
|
18,476 | $1,327,685 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
This page
|
6,351 | $1,070,397 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
21,532 | $529,902 |
All Filings in NBIX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,070,397 | 6,351 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $638,807 | 4,849 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $814,529 | 5,743 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $615,847 | 4,387 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $341,625 | 2,718 | Shares | Sole | 2025-07-25 | |
| 2024-12-31 | $242,970 | 1,780 | Shares | Sole | 2025-08-08 | |
| 2024-06-30 | $207,193 | 1,505 | Shares | Sole | 2024-07-15 | |
| No filing history on record for this holder in this stock. | ||||||